The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer
Simon Müller(Martin Luther University Halle-Wittenberg), Stefan Hüttelmaier(Martin Luther University Halle-Wittenberg)
Cited by 157
Related Papers
Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
|Cellular and Molecular Life Sciences|2012|805
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner
|Nucleic Acids Research|2018|408